Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

VALEANT ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Fund Managers, Institutional and Large Individual Investors With Losses in Excess of $1 Million of Lead Plaintiff Deadline in Class Action Lawsuit Against Valeant Pharmaceut

NEW ORLEANS, LA--(Marketwired - November 05, 2015) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind fund managers and investors that they have until December 21, 2015 to file lead plaintiff applications in a securities class action lawsuit against Valeant Pharmaceuticals International, Inc. (VRX) if they purchased the Company's securities between February 28, 2014 through October 21, 2015, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of New Jersey.

What You May Do

If you purchased shares of Valeant or are a fund manager, institutional or large individual investor, and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss...


More